Janet L. Stanford

Fred Hutch Cancer Center

Papers

1

Total Citations

64

H-Index

1

About

Dr. Janet L. Stanford is a leading epidemiologist whose research has fundamentally shaped our understanding of prostate cancer etiology, progression, and treatment outcomes. Her work spans genetic susceptibility, lifestyle risk factors, and comparative effectiveness research in prostate cancer management. Among her most impactful contributions is a landmark 2015 study examining the comparative harms of open versus robotic prostatectomy using population-based samples, which critically evaluated the real-world trade-offs of surgical approaches that had been widely adopted without definitive evidence of superiority. This study, cited over 60 times, exemplifies her commitment to evidence-based urologic oncology. Dr. Stanford’s broader body of work has been instrumental in identifying how modifiable factors like obesity, smoking, and physical activity influence prostate cancer aggressiveness and survival. Her research has consistently bridged molecular epidemiology with clinical outcomes, producing findings that directly inform patient counseling and clinical decision-making. Through decades of rigorous population-based studies, Dr. Stanford has established herself as a pivotal figure in prostate cancer epidemiology, with her work cited thousands of times and continuing to guide both prevention strategies and treatment evaluation.

Research Focus

Key Achievements

1
H-Index
1
Papers
64
Total Citations
64
Avg Citations/Paper
🏆 Most Cited Paper
The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples
64 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Fred Hutch Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago